Medicare patients could lose access t... - Fight Prostate Ca...

Fight Prostate Cancer

2,802 members1,032 posts

Medicare patients could lose access to advanced cancer treatment; i.e., Proton Therapy

cujoe profile image
2 Replies

This is very bad news for anyone anticipating or needing proton therapy. .From the article:

"If implemented as written, many cancer institutions would be in the difficult position of not being able to offer their patients proton therapy because the reimbursement rate would not adequately cover the costs for delivering this sophisticated technology. As a result, many proton centers may have to shut their doors, and new ones won’t open as planned. Access to proton therapy would decrease for all patients—especially in rural and underserved areas—not just those covered by Medicare."

fiercehealthcare.com/payer/...

Be Well (In spite of what CMS does) - cujoe

PS Someone with posting privileges at APC might want to re-post this over there.

PSS teamkv took care of the re-post to APC

Written by
cujoe profile image
cujoe
To view profiles and participate in discussions please or .
Read more about...
2 Replies
NPfisherman profile image
NPfisherman

Special thanks to teamkv for the repost and a very special thank you for the post, my K9 Terror Amigo...

It brings to mind the question if people that reside in rural locations and/or are old are...in a word....expendable... How horrible...

For me, I got SBRT at an early stage...My insurance covered it, but it would have been $100,000 for my 3 tx of SBRT out of pocket.... Kind of crazy since each treatment took less than 20 minutes...

Take care,

Don Pescado

Par for the course cujoe ....

You may also like...

Plan D no monthly payment too good to be true?

I posted this on APC, 36 replies so far, but I am still not clear about this \\"specialty...

New strategies against bone metastases from prostate cancer - Science Daily

best for an individual patient, one at time, and truly provide a personalized therapy. If I had...

[i][b]How Prostate Cancer May Begin - ScienceDaily, September 21, 2022[/b][/i]

morphologically normal tissue from cancerous and non-cancerous prostates, Molecular Cancer,...

New Era of Lutetium-PSMA Post Approval: Perspectives, Challenges & Future

they had everything available for their patients what would they choose.  The issues and choices...

Efficacy and safety of BAT in CRPC following Abi or Enza resistance: A systematic review

androgen therapy (BAT) is a new endocrinologic treatment for castration-resistant prostate cancer...